Randomized trial · people
Linaclotide raised weekly bowel movements in kids with constipation
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In a large placebo-controlled trial, linaclotide gave children aged 6-17 with functional constipation 1.17 more spontaneous bowel movements a week than placebo, with diarrhea as the main side effect.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 330
- Published
- 2024
- Journal
- Lancet Gastroenterol Hepatol
What they tested
The team tested whether linaclotide works and is safe in children aged 6-17 with functional constipation.
How the study was done
A randomized, double-blind, placebo-controlled phase 3 trial at 64 sites in the USA, Canada, Israel, Italy, the Netherlands, Ukraine and Estonia. It enrolled 330 children aged 6-17, who took linaclotide 72 μg by mouth or a placebo (a dummy pill) once a day for 12 weeks; 328 who got at least 1 dose were analyzed.

What they found
Spontaneous bowel movements, meaning ones that happened without rescue medicine, rose by 2.22 per week in the linaclotide arm and by 1.05 per week on placebo, a difference of 1.17 per week (p<0.0001). Stool consistency also improved more with linaclotide than with placebo (change of 1.11 vs 0.69, p=0.0001). Diarrhea was the most common side effect on linaclotide, in 4% of children vs 2% on placebo. A 17-year-old girl on linaclotide had severe diarrhea that led to dehydration and a hospital stay, and it cleared up after IV fluids; no one died.
What it doesn’t show
The trial lasted 12 weeks and tested a single dose, so it does not show longer-term effects or how other doses compare. It was funded by AbbVie and Ironwood Pharmaceuticals.
The paper
Di Lorenzo et al. Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Gastroenterol Hepatol. 2024.
The compound
More studies on Linaclotide
- Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTsMeta-analysis · people · 2026
- Linaclotide: bowel prep scores similar to double-dose PEGMeta-analysis · people · 2025
- Linaclotide beat placebo in IBS-C and chronic constipation trialsMeta-analysis · people · 2013
- Linaclotide plus 1 L PEG-Asc: 92% vs 86% adequate prep vs sennaRandomized trial · people · 2025
- Linaclotide: trend to more bowel movements in kids at higher dosesRandomized trial · people · 2024
- Linaclotide beat placebo for chronic constipation in 12-week trialsRandomized trial · people · 2011
- Every study on Linaclotide
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.